AGP Executive Report
Last update: 4 hours agoDrug Safety Recall: The UK MHRA issued an urgent recall of Crescent Pharma ramipril 2.5mg capsules after a packaging mix-up may include blister strips labeled as 10mg, raising the risk of dizziness, faintness, and kidney issues for vulnerable patients. Medication Access Crunch: Britain also extended a serious shortage protocol for ramipril 1.25mg, forcing pharmacies to ration supplies to one month at a time until July 24. Pharmacy Care Shift: England’s Pharmacy First model is set to expand from autumn 2026, with pharmacists able to independently prescribe for five additional common conditions, aiming to cut GP and urgent care pressure. Maternal Mental Health & Autism: A large review in The Lancet finds parental depression is linked to autism/ADHD diagnoses, but antidepressants during pregnancy don’t appear to add significant risk once family and baseline factors are considered. Global Health & Conflict: A Sudanese medical group accused forces linked to the Rapid Support Forces of killing 27 civilians in an attack on villages during a major Muslim holiday. Regenerative Medicine Deal: Japan’s HELENE Omotesando Clinic signed an MOU to evaluate stem-cell treatment and cell processing at an Indonesia clinic, pending local approvals. Public Health Systems: An audit in Maryland found the Medicaid agency lacked effective processes to flag questionable payments to dead or incarcerated people.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
